This page shows the latest Fluarix Quadrivalent news and features for those working in and with pharma, biotech and healthcare.
GSK joined the club when its Fluarix Quadrivalent was approved by the FDA last December, and since then Sanofi has also been given a green light for its Fluzone Quadrivalent, giving ... This year the WHO also made recommendations for quadrivalent
It becomes the third major four-strain influenza vaccine approved in the US following FDA backing for AstraZeneca's FluMist Quadrivalent in March 2012 and GlaxoSmithKline's (GSK) Fluarix Quadrivalent nine ... which is approved in people aged two to 49,
Will be sold as Influsplit Tetra in Germany and Fluarix Tetra in the UK. ... GSK launched its four-strain version in the US last December under the Fluarix Quadrivalent name, and with AstraZeneca/Medimmune's FluMist Quadrivalent already on the market,
More from news
Approximately 0 fully matching, plus 3 partially matching documents found.
3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...